Acutus Medical is an electrophysiology company committed to transforming how electrophysiologists (EPs) image, diagnose and treat complex arrhythmias. The company has developed a proprietary advanced technology that accurately maps AFIB and other complex arrhythmias which serves to identify the mechanism of the arrhythmia, as well as provide guided ablation therapy. This technology can show the effectiveness of the therapy in real-time. After each ablation has been delivered and upon the next heartbeat, a new complete map is rendered immediately to show how the therapy changed the electrical pattern inside the heart.
This can continue until the EP is satisfied with the therapy and the procedure is completed. Deerfield invested in Acutus through its $75 million Series C Preferred offering. Proceeds from the Series C financing will allow the company to continue to develop the suite of AcQMap products necessary to perform any catheter-based procedure, to expand its clinical programs worldwide and to build a U.S. and European sales force in preparation for commercialization in both geographies.